Back to search

Democritus University of Thrace (DUTH)

Structural and functional analysis of the clonotypic B cell receptor in patients with B cell lymphomas

Abstract

dc:description

B-cell lymphomas, including chronic lymphocytic leukemia (CLL) and splenic marginal zone lymphoma (SMZL), as well as pre-lymphomatous conditions, including CLL-like monoclonal B lymphocytosis (MBL), exemplify the close interplay between clonal evolution, antigen selection, and immune regulation. At the heart of this process lies the clonotypic B-cell receptor immunoglobulin (BcR IG), which not only mediates interactions with the microenvironment but also carries the molecular imprints of past and ongoing antigenic encounters. Despite decades of research, the precise contribution of the BcR to lymphomagenesis remains incompletely understood. This thesis aimed to dissect the immunogenetic, molecular, and functional properties of the BcR IG across different stages and subtypes of B-cell malignancies, with the aim of clarifying how BcR-mediated signaling and (auto)antigen reactivity shape disease onset, heterogeneity, and evolution. In Part I, we investigated CLL-like MBL, the recognized precursor condition to CLL. High-throughput sequencing, intraclonal diversification analysis, gene expression and (auto)antigen reactivity profiling supported that low-count and high-count CLL-like MBL are biologically distinct entities. Importantly, clonal size, repertoire restrictions, and somatic hypermutation (SHM) patterns emerged as early determinants of progression risk, underscoring the central role of BcR-mediated dynamics in the transition to overt leukemia. In Part II, we focused on CLL stereotyped subset #201, defined by the expression of IGHV4-34/IGLV1-44 BcRs. We demonstrated that SHM recurrently introduces N-linked glycosylation motifs into the variable domains. Functional assays with recombinant monoclonal antibodies revealed that these motifs significantly modulate (auto)antigen-binding capacity, narrowing polyreactivity and refining antigen recognition. These results highlight SHM-induced glycosylation as an important mechanism shaping CLL biology. In Part III, we dissected the immune dynamics, of CLL stereotyped subset #4, a clinically indolent and biologically distinctive subgroup of CLL, defined by the expression of IGHV4-34/IGKV2-30 BcR of the gamma isotype (IgG+). Compared with non-subset IGHV4-34 CLL, subset #4 displayed greater intraclonal diversity and evidence of ongoing clonal evolution. A minor IgM+ subpopulation was consistently detected alongside the dominant IgG+ clone. Within this IgM+ cell fraction we detected IGHV4-34 gene rearrangements clonally related to the dominant IgG+ clonotype. Clonotypic IGHV4-34 gene rearrangements within both subpopulations (IgM+, IgG+) were broadly polyreactive, while somatically hypermutated IgG+ clonotypes showed a more narrow and attenuated antigen binding. Transcriptomic profiling indicated metabolic activity in IgM+ cells and functional anergy in IgG+ cells, alluding to distinct evolutionary trajectories. Collectively, these findings refine the immunogenetic and functional profile of subset #4 and highlight the value of combining high-throughput repertoire analysis with transcriptomic profiling to unravel the mechanisms of clonal dynamics in CLL. In Part IV, we provided a comprehensive structural and functional analysis of the clonotypic BcR IG in SMZL. SMZL-derived BcR IGs were consistently auto/polyreactive, binding to a broad spectrum of self-antigens and microbial targets. Particularly notable was the role of IGHV1-2*04, which encodes a unique tryptophan residue at position 75 of the VH FR3 (W75) that critically shapes antigen binding and BcR self-association. Mutagenesis experiments showed that W75 alters (auto)antigen reactivity, while structural studies revealed conserved BcR homotypic interactions. Altogether, these results highlight how SMZL pathogenesis is likely fueled by a combination of chronic antigen-dependent and antigen-independent BcR signaling, offering mechanistic insights with potential therapeutic relevance. Overall, this work underscores that the natural history of B-cell malignancies is intricately connected to the biology of the BcR IG. Antigenic drive, clonal evolution, and autonomous signaling form an interwoven triad that determines clonal fate across the spectrum from MBL to overt lymphoma and leukemia. By elucidating the molecular and structural basis of these processes, this thesis advances our understanding of disease ontogeny and evolution, while also pointing to new opportunities for targeted intervention.

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Iatrou, Anastasia
  • Ιατρού, Αναστασία

Subjects

dc:subject × 19

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/60370

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Iatrou, Anastasia; Ιατρού, Αναστασία. Structural and functional analysis of the clonotypic B cell receptor in patients with B cell lymphomas. Democritus University of Thrace (DUTH), 2025. http://hdl.handle.net/10442/hedi/60370